We observed increased PERK and IRE1 protein levels in GRP78 inhibited macrophages (Figure 2A), suggesting that elevated UPR signaling promotes an M2 macrophage response, which may have negative implications in cancer therapy efficacy. Here, HSPA5 is linked to cancer.